Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced antibody cross-reactivity following infection with B.1.1.7 than with parental SARS-CoV-2 strains
Nikhil Faulkner, Kevin W. Ng, Mary Wu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 22

Showing 22 citing articles:

SARS-CoV-2 variants, spike mutations and immune escape
William T. Harvey, Alessandro M. Carabelli, Ben Jackson, et al.
Nature Reviews Microbiology (2021) Vol. 19, Iss. 7, pp. 409-424
Open Access | Times Cited: 3370
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Novel SARS-CoV-2 variants: the pandemics within the pandemic
Erik Boehm, Ilona Kronig, Richard A. Neher, et al.
Clinical Microbiology and Infection (2021) Vol. 27, Iss. 8, pp. 1109-1117
Open Access | Times Cited: 358
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison J. Greaney, Tyler N. Starr, Rachel Eguia, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 2, pp. e1010248-e1010248
Open Access | Times Cited: 67
One year into the pandemic: Short-term evolution of SARS-CoV-2 and emergence of new lineages
Fernando Gónzález‐Candelas, Marie-Anne Shaw, Tung Gia Phan, et al.
Infection Genetics and Evolution (2021) Vol. 92, pp. 104869-104869
Open Access | Times Cited: 64
The spike glycoprotein of SARS-CoV-2: A review of how mutations of spike glycoproteins have driven the emergence of variants with high transmissibility and immune escape
Pedro F.N. Souza, Felipe Pantoja Mesquita, Jackson L. Amaral, et al.
International Journal of Biological Macromolecules (2022) Vol. 208, pp. 105-125
Open Access | Times Cited: 59
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics
Giulia Dowgier, Agnieszka Hobbs, David Greenwood, et al.
Vaccine (2025) Vol. 54, pp. 126960-126960
Closed Access
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodies
Thandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 38
SARS-CoV-2 variants: levels of neutralisation required for protective immunity
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 26
Cross-Neutralizing Activity Against SARS-CoV-2 Variants in COVID-19 Patients: Comparison of 4 Waves of the Pandemic in Japan
Koichi Furukawa, Lidya Handayani Tjan, Silvia Sutandhio, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 10
Open Access | Times Cited: 21
Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals
Benjamin Trinité, Edwards Pradenas, Sílvia Marfil, et al.
Viruses (2021) Vol. 13, Iss. 6, pp. 1135-1135
Open Access | Times Cited: 18
Heterologous humoral immunity to human and zoonotic coronaviruses: Aiming for the achilles heel
Kevin W. Ng, Nikhil Faulkner, Antoni G. Wrobel, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101507-101507
Open Access | Times Cited: 18
Neutralization of ancestral SARS-CoV-2 and variants Alpha, Beta, Gamma, Delta, Zeta and Omicron by mRNA vaccination and infection-derived immunity through homologous and heterologous variants
Meriem Bekliz, Kenneth Adea, Pauline Vetter, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 13
SARS-CoV-2 specific memory B-cells from individuals with diverse disease severities recognize SARS-CoV-2 variants of concern
Zoë L. Lyski, Amanda E. Brunton, Matt Strnad, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
A SARS-CoV-2 variant elicits an antibody response with a shifted immunodominance hierarchy
Allison J. Greaney, Tyler N. Starr, Rachel Eguia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 11
Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B.1.1.7 infections
Liane Dupont, Luke B. Snell, Carl Graham, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 9
Rare COVID reactions might hold key to variant-proof vaccines
Ewen Callaway
Nature (2021) Vol. 592, Iss. 7852, pp. 20-21
Closed Access | Times Cited: 8
Can proteomics-based approaches further help COVID-19 prevention and therapy?
Vijay Kumar
Expert Review of Proteomics (2021) Vol. 18, Iss. 4, pp. 241-245
Open Access | Times Cited: 6
Rapidly Evolving SARS-CoV-2: A Brief Review Regarding the Variants and their Effects on Vaccine Efficacies
Shahid Nawaz, Sara Janiad, Aiman Fatima, et al.
Infectious Disorders - Drug Targets (2024) Vol. 24, Iss. 4
Closed Access
Previous SARS-CoV-2 infection increases B.1.1.7 cross-neutralization by vaccinated individuals
Benjamin Trinité, Edwards Pradenas, Sílvia Marfil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Persistence of functional memory B cells recognizing SARS-CoV-2 variants despite loss of specific IgG
Stephan Winklmeier, Katharina Eisenhut, Damla Taskin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Functional antibody and T-cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study
Annika Fendler, Lewis Au, Scott Shepherd, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 4
Page 1

Scroll to top